Evidence map›Paper›PMID 28576907›Full record

Observational studyClinical journal of the American Society of Nephrology : CJASN2017

Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones.

Megan Prochaska, Eric Taylor, Anand Vaidya, Gary Curhan

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Clinical journal of the American Society of Nephrology : CJASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Hypophosphatemia in kidney stone formers.Current opinion in nephrology and hypertension · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Obstructive Sleep Apnea and Risk for Incident Vertebral and Hip Fracture in Women.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Article
  14. Idiopathic Osteoporosis and Nephrolithiasis: Two Sides of the Same Coin?International journal of molecular sciences · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Megan ProchaskaDivisions of Renal Medicine and.
Eric TaylorChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Anand VaidyaEndocrinology, Diabetes, and Hypertension, and.
Gary CurhanDivisions of Renal Medicine and.
Harvard University · USDiabetes Australia · AUMaine Medical Center · US

Funding

Life Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7M
Premonopausal Hormone Levels and Risk of Breast CancerR01CA067262 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI HANKINSON, SUSAN E · 2002 to 2011
$11.9M
TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007527 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1986 to 2021
$8.8M
Interactions Between Adrenal and Parathyroid Hormones in Human HealthR01DK107407 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, ANAND · 2015 to 2019
$2.5M
Sex-related differences in incidence rates of nephrolithiasisK24DK091417 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI CURHAN, GARY C. · 2011 to 2020
$1.5M
Identifying Risk Factors and Improving Risk Assessment for NephrolithiasisR01DK094910 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI TAYLOR, ERIC N · 2013 to 2016
$1.1M
Vitamin D and Hormonal Mechanisms of Cardiovascular Disease in ObesityK23HL111771 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, ANAND · 2012 to 2016
$805k
Circadian Rhythm Disruption and Bisphosphonates as risk factors for Kidney StonesF32DK111056 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI PROCHASKA, MEGAN L · 2016 to 2017
$159k
Doris Duke Charitable Foundation 2015085NCI NIH HHS R01 CA067262NCI NIH HHS UM1 CA176726NHLBI NIH HHS K23 HL111771NIDDK NIH HHS F32 DK111056NIDDK NIH HHS K24 DK091417NIDDK NIH HHS R01 DK094910NIDDK NIH HHS R01 DK107407NIDDK NIH HHS T32 DK007527
6 · The paper itself

Abstract

BACKGROUND AND

objectivesPrevious studies have demonstrated lower bone density in patients with kidney stones, but no longitudinal studies have evaluated kidney stone risk in individuals with low bone density. Small studies with short follow-up reported reduced 24-hour urine calcium excretion with bisphosphonate use. We examined history of low bone density and bisphosphonate use and the risk of incident kidney stone as well as the association with 24-hour calcium excretion. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a prospective analysis of 96,092 women in the Nurses' Health Study II. We used Cox proportional hazards models to adjust for age, body mass index, thiazide use, fluid intake, supplemental calcium use, and dietary factors. We also conducted a cross-sectional analysis of 2294 participants using multivariable linear regression to compare 24-hour urinary calcium excretion between participants with and without a history of low bone density, and among 458 participants with low bone density, with and without bisphosphonate use.

resultsWe identified 2564 incident stones during 1,179,860 person-years of follow-up. The multivariable adjusted relative risk for an incident kidney stone for participants with history of low bone density compared with participants without was 1.39 (95% confidence interval [95% CI], 1.20 to 1.62). Among participants with low bone density, the multivariable adjusted relative risk for an incident kidney stone for bisphosphonate users was 0.68 (95% CI, 0.48 to 0.98). In the cross-sectional analysis of 24-hour urine calcium excretion, the multivariable adjusted mean difference in 24-hour calcium was 10 mg/d (95% CI, 1 to 19) higher for participants with history of low bone density. However, among participants with history of low bone density, there was no association between bisphosphonate use and 24-hour calcium with multivariable adjusted mean difference in 24-hour calcium of -2 mg/d (95% CI, -25 to 20).

conclusionsLow bone density is an independent risk factor for incident kidney stone and is associated with higher 24-hour urine calcium excretion. Among participants with low bone density, bisphosphonate use was associated with lower risk of incident kidney stone but was not independently associated with 24-hour urine calcium excretion.

Indexed as

AdultBiomarkersBone DensityBone Density Conservation AgentsCalciumCross-Sectional StudiesDiphosphonatesFemaleHumansIncidenceKidney CalculiLinear ModelsMiddle AgedMultivariate AnalysisNursesProportional Hazards ModelsBiomarkersBone Density Conservation AgentsCalciumDiphosphonatesBody Mass IndexBone DensityCalcium, DietaryCross-Sectional StudiesDiphosphonatesEpidemiologic StudiesFemaleFollow-Up StudiesHumansKidney CalculiLinear ModelsProportional Hazards ModelsProspective StudiesRisk Assessmentrisk factorsThiazides

Identifiers

PMID28576907
PMCPMC5544505
OpenAlexW2620557862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.